NCT00555958View on ClinicalTrials.gov

Vagal Blocking for Obesity Control

NAUnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2014

Conditions
Obesity
Interventions
DEVICE

Active, implantable, intra-abdominal vagal blocking medical device

Intermittent, programmable, intra-abdominal vagal blocking

Trial Locations (5)

2153

Institute of Weight Control, Sydney

4031

University Hospital Basel, Department of Internal Medicine, Basel

5042

Flinders Medical Centre, Bedford Park

7489

National Center for Advanced Laparoscopic Surgery, St. Olavs University Hospital, Trondheim

14000

Instituto Nacional de la Nutrición Salvador Zubiran (INNSZ), Mexico City

Sponsors
All Listed Sponsors
lead

ReShape Lifesciences

INDUSTRY